Evaluation of Efficacy and Safety of THRV-1268 in Long QT Syndrome Type 2 (LQTS 2)

Clinical trial NCT07277582 · RECRUITING

Trial details

NCT number: NCT07277582
Sponsor: Thryv Therapeutics, Inc.
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Long QT Syndrome (LQTS) 2

Start date: 2026-03-07
Primary completion: 2027-06-30
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.